Testing effectiveness (Phase 2)Study completedNCT02247869
What this trial is testing
Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma
Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 100
Showing 20 of 0 results